Skip to main content

Advertisement

Table 1 COPD prevalence dataa

From: Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review

Criteria used to define COPD Country (sample size) Study population Ageb(yr) Prevalence (%)
Symptomsc     
   Cerveri et al., 2003 [15] Italy (18,645) General population 20-44 9.5
   Huchon et al., 2002 [16] France (14,076) General population ≥25 4.1
   Cerveri et al., 2001 [17] 16 countries (14,819) General population 20-44 2.6
Physician reports     
   Cazzola et al., 2009 [18] Italy (15,229) General population NS 2.5
   Schirnhofer et al., 2007 [19] Austria (1,258) General population ≥40 5.6
   Montnemery et al., 2006 [20] Sweden (3,692) General population 20-59 3.6
   Hedman et al., 1999 [21] Finland (3,102) General population 18-65 3.7
   Montnemery et al., 1998 [22] Sweden (8,469) General population 20-59 4.6
   Lundback et al., 1991 [23] Sweden (6,610) General population 35-66 4.1
Functional respiratory tests     
   Miravitlles et al., 2009 [24] Spain (4,274) General population 56.6 (10.7) 10.2
   Van Durme et al., 2009 [25] Netherlands (7,983) General population ≥55 11.6
   Hansen et al., 2008 [26] Denmark (4,757) General population 45-84 12.0
   Bednarek et al., 2008 [27] Poland (1,960) Primary care 56.7 (11.6) 9.3
   Roche et al., 2008 [28] France (4,764) Health prevention center 59.9 (10.1) 2.6
   Buist et al., 2007 [8] Austria (1,258) General population ≥40 26.1d
  Germany (683)    13.3
  Poland (526)    22.1
  Norway (638)    18.8
   Shahab et al., 2006 [29] United Kingdom (8,215) General population 55.5 (13.5) 13.3
   Stavem et al., 2006 [30] Norway (1,619) Occupational cohort 49.8 (5.5) 16.4
   Sichletidis et al., 2005 [31] Greece (6,112) General population 21-80 5.6
   Murtagh et al., 2005 [32] Ireland (2,484) General population 53.3 (8.6) 6.3
   Tzanakis et al., 2004 [33] Greece (888) General population ≥35 8.4
   Hasselgren et al., 2001 [34] Sweden (4,814) General population 43 (14.8) 2.1
   Peña et al., 2000 [35] Spain (3,978) General population 40-69 9.1
   Viegi et al., 2000 [36] Italy (1,727) General population ≥25 11.0 or 18.3
   Jaen et al., 1999 [11] Spain (497) General population 20-70 7.2
   Dickinson et al., 1999 [37] United Kingdom (353) General population 68.25 9.9
   Marco Jordán et al., 1998 [12] Spain (460) General population 40-60 6.8
   Renwick & Connolly, 1996 [38] United Kingdom (783) General practitioner 66.1 9.0
   Brotons et al., 1994 [13] Spain (642) General population 35-65 6.4
   Bakke et al., 1991 [39] Norway (1,275) General population 42 (16.1) 4.5
Models     
   Peabody et al., 2005 [40] Spain Total population ≥30 6.2
  Norway    6.3
  Poland    6.7
   Feenstra et al., 2001 [41] Netherlands Total population ≥20 1.5
   Stang et al., 2000 [42] Spain Total population ≥45 10.3
  Italy    11.1
  France    10.4
  United Kingdom    15.0
  1. aPrevalence estimates are based on symptoms (cough and sputum at least 3 months each year), physician reports, functional respiratory tests (FEV1/FVC ratio <70%, FEV1 <80% of predicted, FEV1/FVC ratio <65%, FEV1/FVC ratio <70% or FEV1/FVC ratio <88% (male)/89% (female)) and models (general population). bAge was reported in various ways distinguished here as follows: "≥ x", minimum age; "x" or "x (y)", mean age or mean age (SD); "x-y", age range i.e. min-max. cThese patients had chronic bronchitis. dThese data are also reported in Schirnhofer et al., 2007 [19]. Abbreviations used: COPD, chronic obstructive pulmonary disease; NS, not specified; FEV1, maximum expiratory volume in 1 second; FVC, forced vital capacity.